Literature DB >> 17036156

Assessment of colonic transit time using MRI: a feasibility study.

Sonja Buhmann1, Chlodwig Kirchhoff, Roland Ladurner, Thomas Mussack, Maximilian F Reiser, Andreas Lienemann.   

Abstract

The aim of this pilot study was to evaluate a new, non-invasive examination method using MRI for the quantification of the colonic transit time after oral administration of gadolinium-saline solution filled capsules. Healthy volunteers without previous or acute symptoms of gastrointestinal disorders were enrolled. After a 3-day diet for the standardization of gastrocolonic content the volunteers swallowed five Gd-DTPA/saline 0.9%-filled capsules. Seven different concentrations of Gd-DTPA/saline 0.9% solution between 1:0 and 0:1 were tested in a dilution series. Following ingestion of capsules, coronal Flash T1 and True Fisp sequences using a 1.5 Tesla system were obtained at 0 h, 3 h, 6 h, 12 h, 24 h, 36 h and 60 h. Sequences were analyzed by two independent experts for locating the capsules. Overall colonic transit time was separately analyzed for both genders. Fifteen healthy volunteers (7 females, 8 males; mean age 34+/-13 years) were enrolled. The phantom study provided the best contrast in both the T1-and T2-weighted sequences defining a ratio of 1:10 for Gd-DTPA/saline 0.9% solution. The mean transit time accounted for 41+/-9 h in women and for 31+/-10 h in men. MRI is an adequate method for the assessment of colonic transit time offering the advantages of no exposure to radiation, short examination time, possible dynamic evaluation of the transit and the practicability in terms of a future adoption to clinical routine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17036156     DOI: 10.1007/s00330-006-0414-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  22 in total

Review 1.  Chronic constipation.

Authors:  Anthony Lembo; Michael Camilleri
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

Review 2.  Non-invasive investigation of gastrointestinal functions with magnetic resonance imaging: towards an "ideal" investigation of gastrointestinal function.

Authors:  W Schwizer; M Fox; A Steingötter
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

3.  Colonic transit scintigraphy. A physiologic approach to the quantitative measurement of colonic transit in humans.

Authors:  B Krevsky; L S Malmud; F D'Ercole; A H Maurer; R S Fisher
Journal:  Gastroenterology       Date:  1986-11       Impact factor: 22.682

4.  [Do the physical characteristics of radiopaque markers modify the results of the measurement of colonic transit time?].

Authors:  J Olmos; L Soifer; J A De Paula; J San Román; E Varela; L Bustos Fernández; O Gadea; A De Paula
Journal:  Acta Gastroenterol Latinoam       Date:  1994

5.  Measurement of colonic transit time using radionuclide imaging: analysis by condensed images.

Authors:  A Notghi; D Kumar; B Panagamuwa; N J Tulley; S R Hesslewood; L K Harding
Journal:  Nucl Med Commun       Date:  1993-03       Impact factor: 1.690

6.  Segmental colonic transit time.

Authors:  P Arhan; G Devroede; B Jehannin; M Lanza; C Faverdin; C Dornic; B Persoz; L Tétreault; B Perey; D Pellerin
Journal:  Dis Colon Rectum       Date:  1981 Nov-Dec       Impact factor: 4.585

7.  Simplified assessment of segmental colonic transit.

Authors:  A M Metcalf; S F Phillips; A R Zinsmeister; R L MacCarty; R W Beart; B G Wolff
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

8.  Digestive disease as a national problem. II. A white paper by The American Gastroenterological Association, 1967.

Authors: 
Journal:  Gastroenterology       Date:  1967-12       Impact factor: 22.682

9.  Constipation with colonic inertia. A manifestation of systemic disease?

Authors:  A Watier; G Devroede; A Duranceau; M Abdel-Rahman; C Duguay; M D Forand; L Tétreault; P Arhan; J Lamarche; M Elhilali
Journal:  Dig Dis Sci       Date:  1983-11       Impact factor: 3.199

10.  Mechanisms of idiopathic constipation: outlet obstruction.

Authors:  H Martelli; G Devroede; P Arhan; C Duguay
Journal:  Gastroenterology       Date:  1978-10       Impact factor: 22.682

View more
  7 in total

1.  How many segments are necessary to characterize delayed colonic transit time?

Authors:  Michel Bouchoucha; Ghislain Devroede; Cyriaque Bon; Jean-Jacques Raynaud; Bakhtiar Bejou; Robert Benamouzig
Journal:  Int J Colorectal Dis       Date:  2015-06-11       Impact factor: 2.571

2.  Colonic total and segmental transit times in healthy Italian adults.

Authors:  F Pomerri; G Dodi; M Nardin; P C Muzzio
Journal:  Radiol Med       Date:  2009-05-30       Impact factor: 3.469

Review 3.  Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors.

Authors:  Susan Hua
Journal:  Front Pharmacol       Date:  2020-04-28       Impact factor: 5.810

Review 4.  Significance of Ligand-Anchored Polymers for Drug Targeting in the Treatment of Colonic Disorders.

Authors:  Pramila Chaubey; Munira Momin; Sujata Sawarkar
Journal:  Front Pharmacol       Date:  2020-02-25       Impact factor: 5.810

Review 5.  Imaging Measurement of Whole Gut Transit Time in Paediatric and Adult Functional Gastrointestinal Disorders: A Systematic Review and Narrative Synthesis.

Authors:  Hayfa Sharif; David Devadason; Nichola Abrehart; Rebecca Stevenson; Luca Marciani
Journal:  Diagnostics (Basel)       Date:  2019-12-13

Review 6.  Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.

Authors:  Hazem Choukaife; Salma Seyam; Batoul Alallam; Abd Almonem Doolaanea; Mulham Alfatama
Journal:  Int J Nanomedicine       Date:  2022-09-07

7.  Novel MRI tests of orocecal transit time and whole gut transit time: studies in normal subjects.

Authors:  G Chaddock; C Lam; C L Hoad; C Costigan; E F Cox; E Placidi; I Thexton; J Wright; P E Blackshaw; A C Perkins; L Marciani; P A Gowland; R C Spiller
Journal:  Neurogastroenterol Motil       Date:  2013-10-25       Impact factor: 3.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.